FDA finds big issue with Chinese OTC drug manufacturer

4th February 2019 Uncategorised 0

Another Chinese drugmaker has run afoul of the FDA. After banning the imports of Hangzhou Guoguang Touring Commodity in October, the agency has now slapped its finished pharmaceutical plant with a warning letter.

More: FDA finds big issue with Chinese OTC drug manufacturer
Source: fierce